When cancer changes your world, we offer expert care, support and latest treatment.
Crosson Cancer Institute
Comprehensive Cancer Care, Centered on You
At the Crosson Cancer Institute at Providence St. Jude Medical Center in Fullerton, you will find many of today’s most effective approaches to cancer treatment. As one of the nation’s leading cancer programs, we offer patients and families a range of options, including nationally respected experts, clinical trials and immunotherapy, less invasive surgical techniques, and the latest image-guided radiation therapy. We bring together fellowship-trained surgeons, medical oncologists and other cancer specialists, advanced research, and comprehensive support services to help ensure you receive the most effective treatment. Our specialists share one goal: to provide life-saving, life-changing care.
Cancers Treated at St. Jude Medical Center
The Crosson Cancer Institute delivers care backed by deep subspecialty expertise, cutting-edge research, and the latest treatment innovations.
- Anal Cancer
- Bladder Cancer
- Brain and Nervous System Cancers
- Breast Cancer
- Cervical Cancer
- Colon Cancer
- Endocrine Cancer
- Esophageal Cancer
- Gallbladder Cancer
- Gastrointestinal Cancer
- Gynecologic Cancer
- Head and Neck Cancer
- Kidney (Renal) Cancer
- Leukemia
- Liver Cancer
- Lung Cancer
- Lymphoma
- Multiple Myeloma
- Neuroendocrine Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Prostate Cancer
- Rectal Cancer
- Sarcoma
- Skin Cancer
- Stomach Cancer
- Testicular Cancer
- Urologic Cancer
PLUVICTO®: Transformative Treatment for Prostate Cancer
PLUVICTO® treats metastatic prostate cancer in patients who developed resistance to other standard treatments. Now, patients don’t need to undergo chemotherapy prior to being eligible for PLUVICTO®.
A targeted radioligand therapy, PLUVICTO® reaches cancer cells throughout the body while preserving healthy cells, helping to reduce tumor burden and alleviate symptoms.
Find a Doctor
At Providence, you'll have access to a vast network of dedicated and compassionate providers who offer personalized care by focusing on treatment, prevention and health education.
Recognition
U.S. News & World Report - High Performing Hospital in Colon Cancer Surgery (2025-26)
U.S. News & World Report - High Performing Hospital in Leukemia, Lymphoma, & Myeloma (2025-26)
Providence Oncologist Helps Advance Breakthrough Cancer Study
A new study published in Nature Medicine journal highlights the promising research for patients with cancers resistant to immunotherapy. The study focuses on a first-in-class antibody called linavonkibart and its use alongside the immunotherapy drug pembrolizumab for a new treatment.
Early results show the treatment helped restart the immune system and shrink tumors in several complex cancers, like bladder, head and neck, kidney, and melanoma. Side effects were generally manageable by patients.
Dr. David Park, medical oncologist at Providence St. Jude Medical Center, co-authored this publication – reflecting our commitment to bringing innovative research and care to our patients.
